Financial Counselors Inc Novartis Ag Transaction History

Financial Counselors Inc

  • $6.18 Billion
  • Q2 2024

A detailed history of Financial Counselors Inc transactions in Novartis Ag stock. As of the latest transaction made, Financial Counselors Inc holds 260,188 shares of NVS stock, worth $28.8 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
260,188
Previous 256,538 1.42%
Holding current value
$28.8 Million
Previous $24.8 Million 11.63%
% of portfolio
0.45%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
BUY
$92.57 - $107.37 $337,880 - $391,900
3,650 Added 1.42%
260,188 $27.7 Million
Q1 2024

May 02, 2024
SELL
$95.27 - $108.47 $273,615 - $311,525
-2,872 Reduced 1.11%
256,538 $24.8 Million
Q4 2023

Jan 26, 2024
SELL
$92.27 - $101.54 $250,513 - $275,681
-2,715 Reduced 1.04%
259,410 $26.2 Million
Q3 2023

Nov 07, 2023
BUY
$94.73 - $105.13 $45,754 - $50,777
483 Added 0.18%
262,125 $26.7 Million
Q2 2023

Jul 27, 2023
SELL
$92.52 - $104.91 $163,020 - $184,851
-1,762 Reduced 0.67%
261,642 $26.4 Million
Q1 2023

May 02, 2023
SELL
$80.03 - $92.81 $313,637 - $363,722
-3,919 Reduced 1.47%
263,404 $24.2 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $78,496 - $96,128
-1,039 Reduced 0.39%
267,323 $24.3 Million
Q3 2022

Nov 01, 2022
SELL
$74.61 - $87.26 $104,976 - $122,774
-1,407 Reduced 0.52%
268,362 $20.4 Million
Q2 2022

Aug 02, 2022
BUY
$80.52 - $93.75 $626,848 - $729,843
7,785 Added 2.97%
269,769 $22.8 Million
Q1 2022

Apr 28, 2022
BUY
$80.11 - $90.62 $2.07 Million - $2.35 Million
25,878 Added 10.96%
261,984 $23 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $1.26 Million - $1.39 Million
-15,771 Reduced 6.26%
236,106 $20.7 Million
Q3 2021

Oct 26, 2021
BUY
$81.78 - $95.14 $358,359 - $416,903
4,382 Added 1.77%
251,877 $20.6 Million
Q2 2021

Aug 03, 2021
BUY
$85.24 - $94.15 $158,290 - $174,836
1,857 Added 0.76%
247,495 $22.6 Million
Q1 2021

Apr 29, 2021
BUY
$83.5 - $98.47 $302,938 - $357,249
3,628 Added 1.5%
245,638 $21 Million
Q4 2020

Feb 10, 2021
BUY
$78.07 - $94.43 $1.02 Million - $1.23 Million
13,058 Added 5.7%
242,010 $22.9 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $158,694 - $175,812
1,932 Added 0.85%
228,952 $19.9 Million
Q2 2020

Aug 07, 2020
BUY
$80.93 - $91.1 $1.54 Million - $1.73 Million
19,016 Added 9.14%
227,020 $19.8 Million
Q1 2020

Apr 23, 2020
BUY
$70.67 - $99.01 $598,433 - $838,416
8,468 Added 4.24%
208,004 $17.2 Million
Q4 2019

Jan 31, 2020
BUY
$84.35 - $95.37 $231,034 - $261,218
2,739 Added 1.39%
199,536 $18.9 Million
Q3 2019

Nov 08, 2019
SELL
$85.54 - $94.26 $217,357 - $239,514
-2,541 Reduced 1.27%
196,797 $17.1 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $23,600 - $29,046
313 Added 0.16%
199,338 $18.2 Million
Q1 2019

May 10, 2019
BUY
$75.32 - $86.15 $155,761 - $178,158
2,068 Added 1.05%
199,025 $19.1 Million
Q4 2018

Feb 01, 2019
BUY
$73.66 - $82.02 $14.5 Million - $16.2 Million
196,957 New
196,957 $16.9 Million
Q3 2018

Oct 30, 2018
SELL
$66.94 - $77.43 $13.4 Million - $15.4 Million
-199,436 Closed
0 $0
Q2 2018

Aug 03, 2018
SELL
$64.91 - $73.36 $243,737 - $275,466
-3,755 Reduced 1.85%
199,436 $15.1 Million
Q1 2018

Apr 26, 2018
BUY
$70.39 - $84.15 $785,904 - $939,534
11,165 Added 5.81%
203,191 $16.4 Million
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $70,449 - $75,621
974 Added 0.51%
192,026 $16.1 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $180,901 - $188,538
2,440 Added 1.29%
191,052 $16.4 Million
Q2 2017

Aug 10, 2017
BUY
N/A
188,612
188,612 $15.7 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email